ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
-9.19%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$210M
AUM Growth
+$210M
Cap. Flow
+$4.88M
Cap. Flow %
2.32%
Top 10 Hldgs %
61.11%
Holding
46
New
9
Increased
9
Reduced
9
Closed
7
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HARP
26
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.47M 1.16% +497,500 New +$2.47M
MIST icon
27
Milestone Pharmaceuticals
MIST
$156M
$2.44M 1.14% +380,000 New +$2.44M
IOVA icon
28
Iovance Biotherapeutics
IOVA
$807M
$1.98M 0.92% 118,856 -61,139 -34% -$1.02M
ATHA icon
29
Athira Pharma
ATHA
$15.3M
$1.89M 0.88% 140,030 -170,000 -55% -$2.29M
VSTM icon
30
Verastem
VSTM
$569M
$1.41M 0.66% 996,951 -868,049 -47% -$1.22M
MTEM
31
DELISTED
Molecular Templates, Inc.
MTEM
$1.06M 0.5% 307,125 -15,375 -5% -$53.1K
VTYX icon
32
Ventyx Biosciences
VTYX
$171M
$962K 0.45% +70,877 New +$962K
PYXS icon
33
Pyxis Oncology
PYXS
$79.4M
$808K 0.38% 200,000 -477,753 -70% -$1.93M
DICE
34
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$717K 0.34% +37,500 New +$717K
IMGN
35
DELISTED
Immunogen Inc
IMGN
$262K 0.12% +55,000 New +$262K
SEEL
36
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$248K 0.12% 295,896 -2,204,104 -88% -$1.85M
ENTA icon
37
Enanta Pharmaceuticals
ENTA
$180M
$164K 0.08% +2,300 New +$164K
NUVB icon
38
Nuvation Bio
NUVB
$1.02B
$69K 0.03% 90,832
ACIU icon
39
AC Immune
ACIU
$205M
0
ALDX icon
40
Aldeyra Therapeutics
ALDX
$351M
-500,000 Closed -$2M
GOSS icon
41
Gossamer Bio
GOSS
$562M
-119,843 Closed -$1.36M
GRTX
42
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-262,500 Closed -$1.21M
ALPN
43
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
-230,000 Closed -$3.19M
CYT
44
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-391,974 Closed -$4.46M
SRRA
45
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-68,500 Closed -$1.49M